环码 logo — 环码生物致力于
将mRNA科学的全部潜力兑现给患者

环码

环码生物致力于 将mRNA科学的全部潜力兑现给患者

Founded 2021 China China 5 employees Series A Total: $20.00M Biotechnology, Health Care +1

General Information

Company Name 环码
Founded Year 2021
Location China China
Employees 5
Industries Biotechnology, Health Care, Life Sciences
Funding Stage Series A
Social

BounceWatch is an independent company data service, not affiliated with 环码. To contact 环码, visit circodebio.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About 环码

CirCode is an innovative biotechnology company based in China, founded in 2021. The company focuses on the development of Circular RNA therapeutics, with a commitment to realizing the full potential of mRNA science for patients. Compared to linear RNA, circular RNA is more stable and less immunogenic, providing superiority in a broader therapeutic area. CirCode has developed proprietary platform technologies and holds multiple patent families covering this new technology with pending applications worldwide. The company's last investment was a Series A investment on 15 August 2023. The investors in this round included Johnson & Johnson Innovation – JJDC and Chaoxian Fund. CirCode aims to promote the transformation of scientific and technological achievements for the benefit of mankind. For more information, please visit www.circodebio.com.

Taxonomy: Innovative, Circular RNA, Therapeutics, Drug Development, Platform Technologies, Patent, Scientific Advancement, Technological Achievements, Nucleic Acid Drugs, Pharmaceutical, Medical Research, RNA, Biomedical

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Series A Undisclosed 2
Johnson & Johnson Innovation – JJDC, Chaoxian Fund
15 Aug 2023
Seed Round $20.00M 4
EFung Capital, K2VC +2
16 Dec 2021

环码 Alternatives & Competitors

View All Alternatives
环码 vs

A messenger RNA medicines company focused on the development of liver and respiratory rare disease t...

Grant
155 employees
Biotechnology, Health Care
环码 vs
Axolabs
Axolabs Germany

SERVING OLIGONUCLEOTIDE THERAPEUTICS

159 employees
Biotechnology, Life Sciences
环码 vs
etherna
etherna Belgium

Enabling Nucleic Acid Medicines for Next‑Generation Therapies | www.etherna.be

Series B
97 employees
Biotechnology, Health Care

FAQ About 环码

环码生物致力于 将mRNA科学的全部潜力兑现给患者
环码 was founded in 2021.
环码 is headquartered in China.
环码 operates in Biotechnology, Health Care and Life Sciences. Its work centres on Innovative, Circular RNA, Therapeutics and Drug Development.
环码 has approximately 5 employees.
环码 has completed 2 funding rounds, raising a total of $20.00M. The latest funding stage is Series A.
Top alternatives and competitors to 环码 include Arcturus Therapeutics, Axolabs, etherna, Rona Therapeutics, ProQR Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
环码 and Arcturus Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for 环码, https://bouncewatch.com/company/circode, updated 21 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes